It is primarily investigated for its potential therapeutic applications in the treatment of cognitive disorders, particularly Alzheimer's disease. The compound acts as a selective antagonist for the 5-HT6 receptor, which is believed to play a role in memory and learning processes. By targeting this receptor, it aims to improve cognitive function and alleviate symptoms associated with neurodegenerative conditions. Clinical studies have explored its efficacy in enhancing memory and reducing behavioral disturbances in patients. Additionally, its mechanism of action is being studied for potential applications in other central nervous system disorders, such as schizophrenia and anxiety. Research is ongoing to fully understand its benefits and safety profile in various patient populations.